Related Experiment Video

Updated: May 7, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.7K

Research Progress in the Development of Vaccines against Mycoplasma gallisepticum and Mycoplasma synoviae

Shaopeng Wu1, Miaoli Wang2, Xiaoxue Yang2

  • 1Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, College of Animal Science and Veterinary Medicine, Shandong Agricultural University, Tai'an 271018, China.

Microorganisms
|August 29, 2024
PubMed

Insights

Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) cause significant poultry diseases. This review comprehensively examines the development of vaccines for controlling these economically impactful avian mycoplasma infections.

Area of Science:

  • Avian pathology and immunology
  • Veterinary microbiology
  • Vaccine development

Background:

  • Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) are leading causes of respiratory disease and tenosynovitis in poultry.
  • These infections result in substantial economic losses within the global poultry industry.
  • Current treatment options are limited, making vaccination a critical control strategy.

Purpose of the Study:

  • To provide a comprehensive review of vaccine development for Mycoplasma gallisepticum and Mycoplasma synoviae.
  • To summarize advancements in different vaccine types against avian mycoplasmosis.

Main Methods:

  • Literature review of scientific publications on MG and MS vaccines.
  • Analysis of various vaccine platforms including live, inactivated, subunit, and vector vaccines.
  • Synthesis of data on vaccine efficacy and development trends.

Main Results:

  • Multiple vaccine types (live, inactivated, subunit, vector) have been developed for MG and MS.
  • Vaccination remains the primary method for controlling these economically significant poultry diseases.
  • Ongoing research focuses on improving vaccine efficacy and breadth of protection.

Conclusions:

  • Effective vaccines are crucial for managing Mycoplasma gallisepticum and Mycoplasma synoviae in poultry.
  • The review highlights the importance of continued research and development in avian mycoplasma vaccine technology.
  • Vaccination strategies are essential for mitigating economic losses in the poultry sector.
Keywords:
Mycoplasma gallisepticumMycoplasma synoviaeattenuated vaccinesgenetic engineering vaccinevaccine

More Related Videos

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.3K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.2K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
44.3K
Synthetic Biology02:55

Synthetic Biology

Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
4.4K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
115
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
49